Skip to main content
. 2022 Jan 14;11(2):420. doi: 10.3390/jcm11020420
ACEi angiotensin-converting enzyme inhibitors
APA aldosterone-producing adenomas
ARB angiotensin2 receptor blockers
ARR aldosterone-to-renin ratio
AVS adrenal vein sampling
CCB calcium channel blockers
CT computed tomography
CV cardiovascular
DALYs disability-adjusted-life-years
DBP diastolic blood pressure
DOC desoxycorticosterone
DRC direct renin concentration
GRA Glucocorticoid remediable aldosteronism
MRA mineralocorticoid receptor antagonists
MRI magnetic resonance imaging
HTN hypertension
PA primary aldosteronism
PCR polymerase chain reaction
PHA pseudohypoaldosteronism
PGL Paragangliomas
PPGL pheochromocytoma and paraganglioma
PRA plasma renin activity
RAS renin-angiotensin system
RASb renin-angiotensin system blockers